Allergan CEO: 2017 should be Kybella’s breakout year

January 20, 2017 / Botox, Kybella

Allergan CEO: 2017 should be Kybella’s breakout year

Allergan CEO Saunders

Allergan CEO Brent Saunders says Kybella should rack up 20% of its peak sales in chin-fat reduction this year.

 
SAN FRANCISCO—Allergan CEO Brent Saunders is tired of hearing from investors that chin-fat buster Kybella’s launch isn’t going as well as, say, that of IBS-D med Viberzi or schizophrenia treatment Vraylar. So in a Monday presentation at the J.P. Morgan Healthcare Conference, he did his best to set the record straight.